Tumor volume as a prognostic factor on the median survival in locally advanced oral cancer treated with definitive chemoradiotherapy
Indian Journal of Cancer · 2023-01 · 60 (1) · 72-79
DOI: 10.4103/ijc.ijc_86_20 ↗Abstract
Background: Surgery has been the mainstay treatment for oral cancer. Patients who do not receive surgery are generally treated with concurrent chemoradiotherapy (CCRT). Many factors play a role in patients’ survival; tumor volume might be one of those factors. This study aims to determine the effect of the pre-treatment tumor volume on the survival of oral cancer. Methods: Retrospective study of patients with histological confirmed squamous cell carcinoma, stage III–IV oral cancer, who received definitive CCRT. Tumor volume from pre-treatment computed tomography (CT) scans were reviewed and analyzed. The optimal cut-off tumor volume was evaluated by receiver operating characteristic (ROC) curve analysis. Results: Among 67 patients, half of the primary tumor sites were oral tongue. The median total tumor volume (TTV) was 73.25 cm 3 , while the median survival was 12.5 months (95% confidence interval: 10.9-20.3). The optimal cut-off TTV ≥52.9 cm 3 ( P < 0.0001). The median survival of the patients, who had tumor volume
EUVIMED